Please wait while the formulary information is being retrieved.
REGENECARE (lidocaine HCl/collagen)
2 % topical gel
- Dosage information is not available
2 % topical gel
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- Large open wound
- Methemoglobinemia
Contraindicated
- Glucose-6-phosphate dehydrogenase (g6Pd) deficiency
- Heart block
- Hemolytic anemia from pyruvate kinase and g6PD deficienc
- Sepsis
- Shock
Severe
Moderate
- Disease of liver
- Respiratory depression
- Seizure disorder
REGENECARE (lidocaine HCl/collagen)
- None
- None
More Frequent
Severe
Less Severe
- Dermatitis due to topical drug
- Blanching of skin
- Edema
- Erythema
- Pruritus of skin
- Skin rash
- Stinging of skin
- Urticaria
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute respiratory failure
- Anaphylaxis
- Angioedema
- Bradycardia
- Bronchospastic pulmonary disease
- Cardiac arrhythmia
- CNS toxicity
- Cyanosis
- Eyelid edema
- Headache disorder
- Hypotension
- Methemoglobinemia
- Respiratory depression
- Seizure disorder
- Unconsciousness
Less Severe
- Acute cognitive impairment
- Apprehension
- Blurred vision
- Dizziness
- Drowsy
- Euphoria
- Muscle fasciculation
- Nervousness
- Sensation of cold
- Sensation of warmth
- Tinnitus
- Tremor
- Vomiting
Contraindicated
None
Severe Precaution
Lidocaine (Top)
Rare risk of methemoglobinemia in infants age < 6 months. Use dose based on age, body weight and physical condition.
- 1 Day – 179 Days
- Rare risk of methemoglobinemia in infants age < 6 months. Use dose based on age, body weight and physical condition.
Management or Monitoring Precaution
Lidocaine (Top)
Rare risk of methemoglobinemia. Use dose based on age, body weight and physical condition.
- 180 Days – 13 Years
- Rare risk of methemoglobinemia. Use dose based on age, body weight and physical condition.
Lidocaine
- Severity Level:
2
- Additional Notes: Insufficient human data available.
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
Lidocaine
Amount excreted reported to be low with low infant oral bioavailability
Avoid using products w/high conc in nipple area, risk of inc level in infant
| General | Excretion Potential | Effect on Infant | Notes |
| No known risks; does not adversely affect lactation | Excreted | Not known; no or inclusive data | Amount excreted reported to be low with low infant oral bioavailability |
Vitamin E (topical)
Amount excreted reported to be low with low infant oral bioavailability
Avoid using products w/high conc in nipple area, risk of inc level in infant
| General | Excretion Potential | Effect on Infant | Notes |
| No known risks; does not adversely affect lactation | Excreted | No adverse effect | Avoid using products w/high conc in nipple area, risk of inc level in infant |
Contraindicated
None
Precaution Exists
Select Anesthetics
General-May be more sensitive to CNS and cardiac adverse reactions. Consider dose reduction due to reduced clearance in the elderly.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | N | Y | Y | N | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- None
Formulary Reference Tool